Lam Research Corp LRCX
We take great care to ensure that the data presented and summarized in this overview for LAM RESEARCH CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LRCX
View all-
Black Rock Inc. New York, NY12.9MShares$1.92 Billion0.32% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8466KShares$69 Million0.36% of portfolio
-
Mediolanum International Funds LTD Dublin 1, L2263KShares$38.9 Million0.36% of portfolio
-
Cibc World Markets Corp New York, NY252KShares$37.4 Million0.17% of portfolio
-
Credit Suisse Ag Zurich, V8242KShares$35.8 Million0.23% of portfolio
-
Eaton Vance Management Boston, MA225KShares$33.4 Million0.12% of portfolio
-
Avalon Investment & Advisory Houston, TX225KShares$33.3 Million3.35% of portfolio
-
Agf Investments Inc. Toronto, A6201KShares$29.8 Million0.69% of portfolio
-
Covington Investment Advisors Inc. Ligonier, PA172KShares$25.5 Million3.02% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I0126KShares$18.6 Million0.64% of portfolio
Latest Institutional Activity in LRCX
Top Purchases
Top Sells
About LRCX
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Insider Transactions at LRCX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2025
|
Douglas R Bettinger Chief Financial Officer & EVP |
SELL
Open market or private sale
|
Direct |
40,080
-3.9%
|
$6,012,000
$150.6 P/Share
|
|
Nov 10
2025
|
Bethany Mayer Director |
BUY
Bona fide gift
|
Indirect |
1,622
+5.04%
|
-
|
|
Nov 10
2025
|
Bethany Mayer Director |
SELL
Bona fide gift
|
Direct |
1,622
-49.8%
|
-
|
|
Nov 07
2025
|
Bethany Mayer Director |
SELL
Open market or private sale
|
Direct |
30
-0.91%
|
$4,770
$159.52 P/Share
|
|
Nov 07
2025
|
Bethany Mayer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+33.22%
|
-
|
|
Nov 07
2025
|
Ho Kyu Kang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+14.47%
|
-
|
|
Nov 07
2025
|
Jyoti Mehra Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+8.13%
|
-
|
|
Nov 07
2025
|
John M. Dineen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+15.18%
|
-
|
|
Nov 07
2025
|
Mark Fields Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+23.5%
|
-
|
|
Nov 07
2025
|
Abhijit Y Talwalkar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+1.46%
|
-
|
|
Nov 07
2025
|
Eric Brandt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+0.56%
|
-
|
|
Nov 07
2025
|
Ita M Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+23.43%
|
-
|
|
Nov 07
2025
|
Michael R Cannon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+0.85%
|
-
|
|
Nov 07
2025
|
Sohail U Ahmed Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,635
+50.0%
|
-
|
|
Nov 06
2025
|
Sohail U Ahmed Director |
BUY
Bona fide gift
|
Indirect |
2,950
+8.08%
|
-
|
|
Nov 06
2025
|
Sohail U Ahmed Director |
SELL
Bona fide gift
|
Direct |
2,950
-100.0%
|
-
|
|
Nov 03
2025
|
Bethany Mayer Director |
SELL
Open market or private sale
|
Direct |
1,298
-44.0%
|
$206,382
$159.99 P/Share
|
|
Oct 31
2025
|
Ho Kyu Kang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
664
-7.64%
|
$104,248
$157.46 P/Share
|
|
Oct 27
2025
|
Ava Harter Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,010
-7.29%
|
$1,414,570
$157.47 P/Share
|
|
Oct 27
2025
|
Ava Harter Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,010
+8.73%
|
$462,770
$77.04 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 295K shares |
|---|---|
| Bona fide gift | 4.57K shares |
| Exercise of conversion of derivative security | 278K shares |
| Open market or private purchase | 9 shares |
| Bona fide gift | 4.57K shares |
|---|---|
| Open market or private sale | 213K shares |
| Payment of exercise price or tax liability | 147K shares |